SENISCA

Splicing Factors for Cell Rejuvenation

SENISCA

senisca.com| BioTech | Exeter, UK

ABOUT

SENISCA developed a patent protected approach to treat ageing and ageing related diseases. As we age, cells become aged, or ‘senescent’ and they behave differently, which leads to tissue and organ damage. SENISCA discovered that splicing regulation declines during ageing and that cells could not only be brought out of senescence but that, by doing so, the cells were also rejuvenated. 

FOUNDERS

Dr. Lorna Harries, Dr. Ben Lee, Kristy Semple

CO-INVESTORS

Longevitytech.fund, R42 Group, University of Exeter

INDUSTRY

BioTech, Longevity

FOLLOW SENISCA